TTR INC
10QSB, 1997-08-14
COMPUTER PERIPHERAL EQUIPMENT, NEC
Previous: RENAISSANCE COSMETICS INC /DE/, 10-Q, 1997-08-14
Next: BROOKS AUTOMATION INC, 10-Q, 1997-08-14






<PAGE>
<PAGE>



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

    /X / Quarterly report under Section 13 or 15(d) of the Securities Exchange
    Act of 1934 for the quarterly period ended June 30, 1997

                                            or

    /  /  Transition report under Section 13 or 15(d) of the Securities Exchange
    Act of 1934

        Commission file number 0-22055

                                    TTR INC.
        (Exact Name of Small Business Issuer as Specified in its Charter)

              Delaware                             11-3223672
    (State or other Jurisdiction of         I.R.S. Employer Number
    Incorporation or Organization)

                     1841 Broadway, New York, New York 10023
                    (Address of Principal Executive Offices)


                                  212-333-3355
                (Issuer's Telephone Number, Including Area Code)

        Check whether the issuer: (1) filed all reports required to be filed by
    Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12
    months (or for such shorter period that the registrant was required to file
    such reports), and (20 has been subject to such filing requirements for the
    past 90 days.

    Yes [X]                  No[ ]

        The number of shares outstanding of the registrant's Common Stock as of
    August 12, 1997 was 4,238,548.

         Transitional Small Business Disclosure Format:
    Yes [ ]                            No [X]




<PAGE>
<PAGE>






                           TTR INC. AND ITS SUBSIDIARY
                          (A Development Stage Company)
                                      Index

    PART I - FINANCIAL INFORMATION:

    Item 1.  Financial Statements *
        Consolidated Balance Sheets -
               December 31, 1996 and June 30, 1997........................1

        Consolidated Statements of Operations -
               For the Six and Three Months ended
               June 30, 1996 and 1997.....................................2

        Consolidated Statements of Cash Flows
               For the Six Months ended June 30, 1996 and 1997............3

        Notes to Consolidated Financial Statements......................4 - 6

    Item 2.  Plan of operations.........................................7 - 9

    PART II. OTHER INFORMATION

    Item 1. Legal Proceedings............................................10

    Item 2. Changes in Securities........................................10

    Item 3. Defaults upon senior securities..............................11

    Item 4. Submission of Matters to a Vote of Security Holders..........11

    Item 5. Other Information............................................11

    Item 6. Exhibits and Reports on Form 8-k.............................11

    Exhibit 27 - Financial Data Schedule.................................12

    Signatures        ...................................................13

    * The Balance Sheet at December 31, 1996 has been taken from the audited
    financial statements at that date. All other financial statements are
    unaudited.



<PAGE>
<PAGE>


                           TTR INC. AND ITS SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                           CONSOLIDATED BALANCE SHEETS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                         December 31,          June 30,
                                                                             1996                1997
                                                                             ----                ----
<S>                                                                      <C>                 <C>        
ASSETS
Current assets
     Cash and cash equivalents                                           $    63,656         $ 1,303,222
     Other current assets                                                    135,828             187,560
                                                                         -----------         -----------
     Total current assets                                                    199,484           1,490,782

Property and equipment - net                                                 373,444             423,095

Deferred financing costs, net of accumulated amortization of
  $181,310 for 1996                                                           62,101               -
Deferred stock offering costs                                                515,664               -
Due from officer                                                              26,000              26,000
Other assets                                                                  14,995             117,448
                                                                         -----------         -----------
     Total assets                                                        $ 1,191,688         $ 2,057,325
                                                                         ===========         ===========
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

LIABILITIES
Current liabilities
     Current portion of long-term debt                                   $ 1,065,365         $    20,656
     Short-term borrowings                                                   849,602               -
     Accounts payable                                                        170,323              17,102
     Accrued expenses                                                        443,594             300,293
     Interest payable                                                        234,508               -
                                                                         -----------         -----------
     Total current liabilities                                             2,763,392             338,051

Long-term debt, less current portion                                          22,153              10,665
                                                                         -----------         -----------
     Total liabilities                                                     2,785,545             348,716
Common stock issued with guaranteed selling price - 
  $.001 par value 15,000 shares issued and outstanding                       -                   232,500
                                                                         -----------         -----------
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock, $.001 par value;
  20,000,000 shares authorized,
  3,050,000 and 4,223,548 issued and outstanding, respectively,
   including 1,000,000 shares placed in escrow                                 3,050               4,224
Additional paid-in capital                                                   405,356           7,794,291
Cumulative translation adjustments                                            57,696              73,561
Deficit accumulated during the development stage                          (2,059,959)         (4,536,012)
  Less: deferred compensation                                                -                (1,859,955)
                                                                         -----------         -----------
     Total stockholders' equity (deficit)                                 (1,593,857)          1,476,109
                                                                         -----------         -----------
     Total liabilities and stockholders' equity (deficit)                $ 1,191,688         $ 2,057,325
                                                                         ===========         ===========
</TABLE>

                       See Notes to Financial Statements.


                                       -1-


<PAGE>
<PAGE>


                           TTR INC. AND ITS SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                     CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)
<TABLE>
<CAPTION>
                                                                                From
                                                                              Inception
                                                      Six Months              (July 14,           Three Months
                                                         Ended                1994) to                Ended
                                                        June 30,              June 30,              June 30,
                                                    1996          1997          1997           1996           1997
                                                    ----          ----          ----           ----           ----
<S>                                             <C>           <C>            <C>            <C>           <C>  
Revenue                                         $  -          $   -          $   -          $  -          $   -

Expenses
     Research and development                      176,320        435,129      1,055,682        91,074        164,150
     Sales and marketing                            61,099        978,651      1,412,449        24,994        652,213
     General and administrative                    195,709        739,714      1,384,450       120,212        392,027
                                                ----------    -----------    -----------    ----------    ----------- 
     Total expenses                                433,128      2,153,494      3,852,581       236,280      1,208,390
                                                ----------    -----------    -----------    ----------    ----------- 
Operating loss                                    (433,128)    (2,153,494)    (3,852,581)     (236,280)    (1,208,390)

Other (income) expense
     Legal settlement                                 -           232,500        232,500          -              -
     Loss on investment                               -              -            17,000          -              -
     Interest income                                  -           (17,069)       (29,893)         -            (6,887)
     Interest expense                               61,553        107,128        463,824        46,784         10,065
                                                ----------    -----------    -----------    ----------    ----------- 
Total other (income) expenses                       61,553        322,559        683,431        46,784          3,178
                                                ----------    -----------    -----------    ----------    ----------- 
Net loss                                        $ (494,681)   $(2,476,053)   $(4,536,012)   $ (283,064)   $(1,211,568)
                                                ==========    ===========    ===========    ==========    =========== 
Net loss per share                              $    (0.19)   $     (0.78)   $     (1.42)   $    (0.11)   $     (0.35)
                                                ==========    ===========    ===========    ==========    =========== 
Weighted average number of 
  shares outstanding                             2,612,582      3,188,973      3,188,973     2,612,582      3,445,109
                                                ==========    ===========    ===========    ==========    =========== 
</TABLE>


                       See Notes to Financial Statements.

                                       -2-


<PAGE>
<PAGE>


                           TTR INC. AND ITS SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                                                                    From
                                                                                                                 Inception
                                                                                   Six Months                     (July 14,
                                                                                     Ended                        1994) to
                                                                                    June 30,                       June 30,
                                                                              1996               1997                1997
                                                                              ----               ----               -----
<S>                                                                        <C>               <C>                  <C>
CASH FLOWS FROM OPERATING ACTIVITIES
     Net loss                                                              $(494,681)        $(2,476,053)         $(4,536,012)
     Adjustments to reconcile net loss
      to net cash used by operating activities:
          Depreciation and amortization                                       59,470             127,737              383,778
          Amortization of discount on long-term debt                           1,960                -                    -
          Translation adjustment                                                 957              60,634               59,106
          Amortization of deferred compensation                                 -                492,356              492,356
          Stock and warrants issued for services and legal settlement           -                565,125              583,798
          Increase (decrease) in cash attributable
           to changes in assets and liabilities
               Accounts receivable                                             1,243                  35                 (280)
               Escrow                                                           -                   -                    -
               Other current assets                                            1,546               5,573             (113,141)
               Other assets                                                     -               (102,700)            (102,700)
               Accounts payable                                              (21,869)           (146,166)              32,003
               Accrued expenses                                               33,598              99,649              219,400
               Interest payable                                               53,560            (234,508)                -
                                                                           ---------         -----------          ------------
        Net cash used by operating activities                               (364,216)         (1,608,318)          (2,981,692)
                                                                           ---------         -----------          ------------
CASH FLOWS FROM INVESTING ACTIVITIES
     Purchases of property and equipment                                     (14,871)           (134,740)            (570,633)
     Increase in organization costs                                             -                   -                  (7,680)
                                                                           ---------         -----------          ------------
        Net cash used by investing activities                                (14,871)           (134,740)            (578,313)
                                                                           ---------         -----------          ------------
CASH FLOWS FROM FINANCING ACTIVITIES
     Proceeds from issuance of common stock                                  363,533           5,220,837            5,610,570
     Loans to officer                                                           -                   -                 (26,000)
     Deferred stock offering costs                                           (40,385)           (309,565)            (475,664)
     Deferred financing costs                                                (64,980)            (19,000)            (262,411)
     Proceeds from short-term borrowings                                     425,000             200,000            1,049,602
     Proceeds from long-term debt                                               -                   -               1,114,137
     Repayment of short-term borrowings                                         -             (1,049,602)          (1,049,602)
     Repayments of long-term debt                                             (6,380)         (1,052,545)          (1,008,561)
                                                                           ---------         -----------          -----------
       Net cash provided by financing activities                             676,788           2,990,125            4,872,071
                                                                           ---------         -----------          -----------
Effect of exchange rates on cash                                                (693)             (7,501)              (8,844)
                                                                           ---------         -----------          -----------
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                             297,008           1,239,566            1,303,222

CASH AT BEGINNING OF PERIOD                                                   87,866              63,656                 -
                                                                           ---------         -----------          -----------
CASH AND CASH EQUIVALENTS AT END OF PERIOD                                 $ 384,874         $ 1,303,222          $ 1,303,222
                                                                           =========         ===========          ===========
SUPPLEMENTAL DISCLOSURES OF 
 CASH FLOW INFORMATION
  Cash paid during the period for:
    Interest                                                               $    -            $   316,262          $   334,718
                                                                           =========         ===========          ===========
</TABLE>

                       See Notes to Financial Statements.

                                       -3-



<PAGE>
<PAGE>



                           TTR INC. AND ITS SUBSIDIARY
                          (A Development Stage Company)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


    Note 1 - Basis of Presentation

       The accompanying unaudited consolidated financial statements of TTR Inc.
       and its Subsidiary ("the Company") have been prepared in accordance with
       generally accepted accounting principles for interim financial
       information and with Item 310(b) of Regulation SB. Accordingly, they do
       not include all of the information and footnotes required by generally
       accepted accounting principles for complete financial statements. In the
       opinion of management, all adjustments (consisting of normal recurring
       accruals) considered necessary for a fair presentation have been
       included. Operating results for the six months ended June 30, 1997 are
       not necessarily indicative of the results that may be expected for the
       year ending December 31, 1997. For further information, refer to the
       consolidated financial statements and footnotes thereto included in the
       Company's Form 10-KSB for the year ended December 31, 1996 as filed with
       the Securities and Exchange Commission.

    Note 2 -  Loss per share

       Net loss per share of common stock is computed based on the weighted
       average number of common stock and common stock equivalent shares
       outstanding during the period. Pursuant to SEC rules, common stock and
       warrants issued for consideration below the public offering price within
       the twelve months prior to filing a registration statement have been
       included in the calculation of common stock equivalents, using the
       treasury stock method, as if they had been outstanding for all periods
       presented. Certain shares held in escrow are not treated as outstanding
       during any period

    Note 3 - Initial Public Offering

       In February 1997, the Company completed an initial public offering of
       860,000 shares of its Common Stock and realized net proceeds of
       approximately $4,700,000 after stock offering costs. In connection with
       this offering, the Company sold to the underwriter, for $80, warrants to
       purchase up to an additional 80,000 shares of the Company's Common Stock
       at an exercise price equal to $11.20 per share. The Company has also
       agreed to retain the Underwriter as management and financial consultants
       for a two-year period at an annual rate of $60,000 per annum, payable in
       advance. In connection with the IPO, certain securityholders have agreed
       not to sell their shares for up to two years from the offering date,
       without the prior written consent of the Underwriter.




                                       -4-


<PAGE>
<PAGE>



                           TTR INC. AND ITS SUBSIDIARY
                          (A Development Stage Company)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


    Note 4 - Long-term Debt and Short-term Borrowings

       In January 1997, the Company issued short-term promissory notes
       aggregating $200,000. Interest is calculated at the rate of 15% per
       annum. In February 1997, upon the completion of the IPO, the Company
       repaid these notes as well a total of $1,900,000 in other long-term debt
       and short-term borrowings, plus accrued interest thereon. All unamortized
       deferred financing costs have been charged off in the period.

    Note 5 - Stock warrants, options and grants

       (1)   Pursuant to an employment agreement with the Chief Executive
             Officer of TTR Israel, the Company granted, on the date the IPO was
             declared effective, warrants to purchase up to 217,473 shares of
             the Company's Common Stock, at an exercise price of $.01 per share.
             The company has recorded deferred compensation expense of
             $1,522,300 and is amortizing this amount over the period that
             services are provided. The options will vest over a four year
             period commencing with the date of grant.

       (2)   On March 11, 1997, the Company issued 5,000 shares of its Common
             Stock to a consultant. The Company has recorded a charge to
             research and development expenses in the amount of $50,000 due to
             the issuance of these shares.

       (3)   On April 15, 1997, the Company granted a total of 19,000 shares of
             its Common Stock for services rendered. The Company has record a
             charge to a charge to sales and marketing expenses of $282,625 from
             the issuance of these shares.

    Note 6 - Employment Agreement

       On March 11, 1997, the Company entered into a one-year employment
       agreement with its Chief Financial Officer. The agreement provides for
       monthly compensation of $5,000 and is automatically renewable for
       additional one-year terms. The Company has also issued to the employee
       50,000 shares of its Common Stock which shares have been placed in
       escrow. Pursuant to the escrow agreement, 25,000 shares will be released
       from escrow on July 31, 1997 and 25,000 on January 31, 1998. The grant of
       these shares results in a charge to deferred compensation in the amount
       of $500,000 which is being amortized over one year. The officer was also
       granted 40,000 qualified and 60,000 nonqualified options to purchase
       shares of the Company's Common Stock, at an exercise price of $10.00 and
       $5.00 per share, respectively. The options will vest over a four-year
       period commencing with the date of grant.

       The issuance of the nonqualified options resulted in a charge to deferred
       compensation in the amount of $300,000. This amount will be amortized
       over the vesting period.

                                       -5-


<PAGE>
<PAGE>



                           TTR INC. AND ITS SUBSIDIARY
                          (A Development Stage Company)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


    Note 7 - Consulting Agreement

       On March 1, 1997, the Company entered into a one year consulting
       agreement which provided for a lump-sum payment of $100,000 to be paid
       upon signing.

    Note 8 - Common Stock Issued with Guaranteed Selling Price

       On March 31, 1997, the Company and TTR Israel were served with claims by
       and individual demanding, among other things, royalties at the rate of 5%
       of the proceeds from the sales of products in which the plaintiff claims
       to have provided consulting services towards its development.

       On May 6, 1997, the Company entered into a settlement agreement whereby
       the plaintiff, Mr. Israel, dismissed the law suit with prejudice in
       consideration of the Company's issuance to him of 15,000 shares of common
       stock. Pursuant to the Settlement Agreement, the Company has agreed to
       register such shares and has guaranteed, under certain circumstances, a
       gross sale price in an ordinary brokerage transaction in  the over-the-
       counter market of $15.50 per share. The Company's obligation shall cease
       if at any time after registration of these shares, for a period of 180
       days, the sale price at which the Company's publicly traded common stock
       trades averages in excess of $15.50 per share for a consecutive 2 day
       period. These shares have since been registered.

       The Company has established a temporary equity account to record its
       maximum liability with respect to the shares ($232,500). Payment of any
       shortfall will be charged to this account. Any balance remaining at the
       end of the holding period will be credited to permanent capital.




                                       -6-


<PAGE>
<PAGE>




    ITEM 2.  PLAN OF OPERATIONS

    The following discussion and exposition should be read in conjunction with
    the Financial Statements and related Notes contained elsewhere in this Form
    10-QSB.

       TTR Inc. ("TTR" or the "Company") is engaged in the design and
    development and marketing of proprietary software security products that are
    designed to prevent the unauthorized reproduction and use of computer
    software and electronic content. TTR's core software protection technologies
    are designed to be used by software publishers for inclusion into their
    software products. The Company is in development stage and, to date, has not
    realized any operating revenues.

       The Company is actively engaged in completing the development and
    commencing the intensive marketing of DiscGuard'tm', its proprietary
    technology designed to protect against the unauthorized reproduction of
    CD-ROM and DVD based content, and anticipates releasing the initial version
    by the fourth quarter of 1997. The Company and Doug Carson and Associates
    Ltd. ("DCA"), a leading supplier of mastering interface systems used by
    CD-DVD/ROM replicators to mass-produce CD-ROMs, have, on April 14, 1997,
    entered into a Memorandum of Understanding ("DCA MOU") providing for,
    inter-alia, the incorporation of the DiscGuard technology into DCA's
    mastering interface systems. DCA and TTR have undertaken under the DCA MOU
    to assist Nimbus CD International Inc. ("Nimbus"), a leading CD-ROM
    replicator, in integrating the DiscGuard enhanced mastering interface system
    into Nimbus' production lines (mastering machines) to produce a first-run of
    1,000 DiscGuard treated CD-ROMs (the "First Run"). On May 11, 1997 the
    Company, DCA and Nimbus entered into a memorandum of understanding (the
    "Nimbus MOU") relating to the principal terms of a proposed license
    agreement granting Nimbus the right to use the DiscGuard technology for the
    purpose of replicating DiscGuard protected CD-ROMs and DVDs (the "Protected
    Media"). Upon successful completion of the First Run, Nimbus shall be
    granted an exclusive six month license to produce Protected Media through
    mastering machines.

       Although no assurances can be given with respect to the successful
    development and marketing of the DiscGuard product, management believes that
    the integration of the DiscGuard technology into DCA's mastering interface
    systems and Nimbus's production lines (mastering machines) will
    expose the Company's DiscGuard product to other CD-ROM and DVD-ROM
    replicators and publishers worldwide, thereby establishing the
    infrastructure necessary for software publishers to integrate the
    Company's technology into their software products.

       The Company has completed development of SoftGuard'tm', its software
    protection solution for non-CD-ROM based software applications, for use on
    Windows 3.x and MS-DOS based systems, but does not intend on currently
    releasing SoftGuard to the public unless prevailing market conditions
    dictate otherwise and the Company develops a sales and other customer
    support infrastructure and distribute

                                       -7-


<PAGE>
<PAGE>




    same using a non-reproducible protected media.

       The Company anticipates undertaking marketing efforts in North America,
    Israel, Europe and the Far East to increase awareness of the Company's
    products. In this respect the Company will be exploring the possibility of
    establishing strategic alliances with appropriate software distributors. In
    addition to the DCA and Nimbus relationship, the Company is exploring with
    CD recording equipment manufacturers the option of incorporating the
    DiscGuard technology into their CD recorders. No assurance can however be
    provided that any agreements will result.

       The Company's product development is centralized out of the facilities of
    its Israeli based subsidiary, TTR Technologies Ltd. ("TTR Israel"), at 2
    Hanagar Street, Kfar Saba 44425 Israel. The Company does not have any
    commitments or plans to undertake significant capital expenditures other
    than computer workstations as it hires new employees which is not expected
    to be more than $150,000.

       The Company currently has 20 employees, and depending on its level of
    business activity, expects to hire an additional 7-10 in the next 12 month
    period.

       To date, the Company has not generated any revenues from operations. In
    February 1997, the Company completed an initial public offering of its
    securities consisting of 860,000 shares of its common stock and realized
    proceeds of approximately $4,700,000 net of deferred stock offering costs.
    For the period from its inception to June 30, 1997, the Company has incurred
    total operating losses of $3,852,581, including the non-cash charges
    associated with the stock option grants and stock grants referred to in
    Notes 5 and 6 of Item 1 and the paragraph below. For the three months period
    ended June 30, 1997, the Company incurred operating losses of $1,208,390.

       The Company's operating expenses have increased relative to previous
    periods, reflecting the Company's growth and expansion since its initial
    public offering. The increase in operating expenses is also due to a
    great extent to certain non-cash charges associated with the compensation
    of senior Company personnel. In 1997, the Company recorded deferred
    compensation in the amount of $2,352,311 in connection with stock options
    and stock grants issued to its chief executive officer and to its newly
    hired chief financial officer. The amortization of this deferred
    compensation resulted in non-cash charges for the first half of 1997 of
    $492,356. Non-cash charges of $282,625 and $50,000 were also charged to
    sales and marketing and research and development, respectively, in
    connection with stock grants to consultants of the Company. The Company
    believes that these compensation charges were necessary to retain the
    services of competent individuals.

       Cash used by operations for the six months ended June 30, 1997 was
    approximately $1,608,318. This amount included the repayment of accrued
    interest in the amount of $305,000, including current period interest of
    $71,000, in February 1997 when the Company repaid substantially all of its
    debt from the proceeds of the offering. In addition, the company prepaid
    $220,000 of fees under two consulting contracts with ten-month and two-year
    terms, respectively. (See notes to financial statement).

                                       -8-


<PAGE>
<PAGE>




       The Company believes that ongoing investment in research and development
    and marketing activities will be critical to the ability of the Company to
    generate revenues and operate profitably. Since its inception, the Company
    has expended approximately $1,055,682 on its research and development
    activities. Management anticipates that the Company will continue to expend
    funds the development activities of DiscGuard and in the effort to market
    its products effectively.

       In April 1997, the Company was approved by the Office of the Chief
    Scientist of the Government of Israel (OCS) for an additional grant of
    $112,500, which amount was subsequently increased to $203,000. To date, the
    Company has received $100,000 and the Company anticipates receiving the
    remaining balance over the course of the next 12 months. These funds will
    partially offset research and development costs.

       The Company expects, but cannot give assurance, that existing cash
    balances and cash flows from activities will be sufficient to meet its
    financing needs for at least the next nine months, including expected
    capital expenditures and working capital to fund operations.



                                       -9-


<PAGE>
<PAGE>




    PART II

    Item 1. Legal Proceedings

       On March 31, 1997, the Company was served with notice of a law suit filed
    with the District Court in Tel Aviv-Jaffa, Israel, by Henry Israel, a former
    consultant to the Company, alleging that an oral agreement exists between
    the Company and Mr. Israel according to which he is entitled to 5% of "the
    rights" in DiscGuard and SoftGuard, including any further developments and
    enhancements therein, as well as any proceeds received therefrom. Management
    believes that the allegations are without merit. Notwithstanding, to avoid
    costly litigation, the Company entered into an agreement with Mr. Israel on
    May 6, 1997 (the "Settlement Agreement") whereby Mr. Israel dismissed the
    law suit with prejudice in consideration of the Company's issuance to him of
    15,000 shares of common stock. Pursuant to the Settlement Agreement, the
    Company has agreed to register such shares and has guaranteed, under certain
    circumstances, a gross sale price in an ordinary brokerage transaction in
    the over-the-counter market of $15.50 per share. The Company's obligation
    shall cease if at any time after registration of these shares, for a period
    of 180 days, the sale price at which the Company's publicly traded common
    stock trades averages in excess of $15.50 per share for a consecutive 2 day
    period. These shares have since been registered.

    Item 2.  Change in Securities

       (C1)  In April 1997, the Company issued 15,000 shares of Common Stock to
             Holborn Systems Ltd., a consultant of the Company, and 4,000 shares
             to Ascent Inner Dimensions of Jewish Life Inc.

             (i) There were no underwriters with respect to the above
                 transaction.

             (ii) The shares were issued in consideration of services
                  rendered.

             (iii) The Company believes that the shares of Common Stock were
                   issued in a transaction not involving a public offering
                   in reliance upon an exemption from registration provided by
                   Section 4(2) of the Securities Act of 1933, as amended.

       (C2)  In May 1997, the Company issued 15,000 shares of Common Stock to
             Henry Israel, a former consultant to the Company.

             (i) There were no underwriters with respect to the above
                 transaction.

             (ii) The shares were issued in consideration of a settlement
                  agreement resolving outstanding litigation. See Item 1.

             (iii) The Company believes that the shares of Common Stock were
                   issued in a transaction not involving a public offering in
                   reliance upon

                                      -10-


<PAGE>
<PAGE>




                   an exemption from registration provided by Section 4(2) of
                   the Securities Act of 1933, as amended.


    Item 3.  Default Upon Senior Securities

               Not Applicable

    Item 4.  Submission of Matters to a Vote of Security Holders

               Not Applicable

    Item 5.  Other Information

               Not Applicable

    Item 6.  Exhibits and Reports on 8-K




                                      -11-


<PAGE>
<PAGE>



    SIGNATURES

       In accordance with the requirements of the Securities Exchange Act of
    1934, the registrant has duly caused this report to be signed on its behalf
    by the undersigned, thereunto duly authorized.


                                     TTR INC.
                                     Registrant

    Date: August 14, 1997            By:    /s/ Marc D. Tokayer
                                            -------------------
                                            Marc D. Tokayer
                                            President (Principal
                                            Executive Officer)
                                            (and duly authorized to sign on
                                            behalf of the Registrant)



                                      -13-



                           STATEMENT OF DIFFERENCES

The trademark symbol shall be expressed as................................'tm'





<PAGE>
 



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>                      This schedule contains summary financial
                              information extracted from the consolidated
                              financial statements accompanying the filing of
                              Form 10-QSB and is qualified in its entirety by
                              reference to such financial statements.

</LEGEND>
       
<S>                                         <C>

<FISCAL-YEAR-END>                            DEC-31-1997  
<PERIOD-END>                                 JUN-30-1997  
<PERIOD-TYPE>                                6-MOS
<CASH>                                         1,303,222  
<SECURITIES>                                           0  
<RECEIVABLES>                                          0  
<ALLOWANCES>                                           0  
<INVENTORY>                                            0  
<CURRENT-ASSETS>                               1,490,782  
<PP&E>                                           423,095  
<DEPRECIATION>                                         0  
<TOTAL-ASSETS>                                 2,057,325  
<CURRENT-LIABILITIES>                            338,051  
<BONDS>                                                0  
<COMMON>                                           4,224  
                                  0  
                                            0  
<OTHER-SE>                                     1,471,885  
<TOTAL-LIABILITY-AND-EQUITY>                   2,057,325  
<SALES>                                                0  
<TOTAL-REVENUES>                                       0  
<CGS>                                                  0  
<TOTAL-COSTS>                                          0  
<OTHER-EXPENSES>                               2,153,494  
<LOSS-PROVISION>                                       0  
<INTEREST-EXPENSE>                               107,128  
<INCOME-PRETAX>                               (2,476,053) 
<INCOME-TAX>                                           0  
<INCOME-CONTINUING>                           (2,476,053) 
<DISCONTINUED>                                         0  
<EXTRAORDINARY>                                        0  
<CHANGES>                                              0  
<NET-INCOME>                                  (2,476,053) 
<EPS-PRIMARY>                                      (0.78) 
<EPS-DILUTED>                                          0  
                                                   
                                               


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission